Filtered By:
Condition: Hemorrhagic Stroke
Management: Hospitals

This page shows you your search results in order of date. This is page number 13.

Order by Relevance | Date

Total 866 results found since Jan 2013.

Clinical characteristics, multiorgan dysfunction and outcomes of patients with COVID-19: a prospective case series
This study provides further evidence that COVID-19 is a multisystem disease involving neurologic, cardiac and thrombotic dysfunction, without evidence of hepatic dysfunction. Patients have persistent organ dysfunction after hospital discharge, underscoring the need for research on long-term outcomes of COVID-19 survivors.PMID:35853662 | DOI:10.9778/cmajo.20210151
Source: cmaj - July 19, 2022 Category: General Medicine Authors: Kimia Honarmand Kyle Fiorini Debarati Chakraborty Daniel Gillett Karishma Desai Claudio Martin Karen J Bosma Marat Slessarev Ian M Ball Tina Mele Danielle LeBlanc Sameer Elsayed Alejandro Lazo-Langner Mike J Nicholson Robert Arntfield John Basmaji Source Type: research

Acute symptomatic seizures and hippocampal sclerosis: the major contributor for post-stroke epilepsy?
AbstractObjectiveHippocampal sclerosis (HS) is a prominent biomarker of epilepsy. If acquired later in life, it usually occurs in the context of degenerative or acute inflammatory-infectious disease. Conversely, acute symptomatic seizures (ASS) are considered a risk factor for developing post-stroke epilepsy, but other factors remain unrecognized. Here, we hypothesize that silent hippocampal injury contributes to the development of post-stroke epilepsy.MethodsWe performed a retrospective observational study of patients hospitalized between 1/2007 and 12/2018 with an acute stroke in the Stroke Center of the Geneva Universit...
Source: Journal of Neurology - July 7, 2022 Category: Neurology Source Type: research

In-hospital outcomes of patients with spontaneous supratentorial intracerebral hemorrhage
The objective of this study is to discover the predicting factors focusing on in-hospital outcomes of patients with spontaneous supratentorial ICH.
Source: Medicine - July 1, 2022 Category: Internal Medicine Tags: Research Article: Observational Study Source Type: research

Neutrophil-to-Lymphocyte Ratio Predicts in-Hospital Mortality in Intracerebral Hemorrhage
Intracerebral hemorrhage is one of the world's three most lethal and disabling diseases, which is the second most common kind of stroke and imposes enormous health, economic and social burdens.1-3 Although clinical examination and neuroimaging are available to assess the severity and progression of intracerebral hemorrhage, more reliable indicators are needed to predict the outcome.4,5 Due to the essential role of inflammatory factors in the development of intracerebral hemorrhage, it has attracted increasing attention as a peripheral biomarker for predicting early mortality in patients with intracerebral hemorrhage.
Source: Journal of Stroke and Cerebrovascular Diseases - June 30, 2022 Category: Neurology Authors: Li Li, Hang Zhang, Gui-long Feng Source Type: research

CUPID research: Finding faster ways to pinpoint the deadliest strokes
Although fewer than one in five strokes is caused by intracerebral hemorrhage (ICH), or bleeding in the brain, this type of stroke is the deadliest. A new study led by Dr. Aarti Sarwal, professor of neurology at Wake Forest University School of Medicine, is examining whether it is possible to identify patients with an ICH stroke before they get to the hospital in order to help these patients get life-saving care without delay. “For ICH, outcomes tend to be much worse if patients get specialized…
Source: bizjournals.com Health Care News Headlines - June 14, 2022 Category: Health Management Authors: Atrium Health Wake Forest Baptist Source Type: news

Pilot Report for Intracranial Hemorrhage Detection with Deep Learning Implanted Head Computed Tomography Images at Emergency Department
AbstractHemorrhagic stroke is a serious clinical condition that requires timely diagnosis. An artificial intelligence algorithm system called DeepCT can identify hemorrhagic lesions rapidly from non-contrast head computed tomography (NCCT) images and has received regulatory clearance.  A non-controlled retrospective pilot clinical trial was conducted. Patients who received NCCT at the emergency department (ED) of Kaohsiung Veteran General Hospital were collected. From 2020 January-1st to April-30th, the physicians read NCCT images without DeepCT. From 2020May-1st to August-31st, the physicians were assisted by DeepCT. The...
Source: Journal of Medical Systems - June 8, 2022 Category: Information Technology Source Type: research

Abstract No. 239 Prognostic value of radiologic signs in hemorrhagic stroke
To examine the prognostic values of radiologic signs in hemorrhagic stroke and in-hospital mortality
Source: Journal of Vascular and Interventional Radiology : JVIR - June 1, 2022 Category: Radiology Authors: X. Liu, T. Morgan, F. Boucher, M. Jumaa Source Type: research

A magnetoimpedance biosensor microfluidic platform for detection of glial fibrillary acidic protein in blood for acute stroke classification
Biosens Bioelectron. 2022 May 20;211:114410. doi: 10.1016/j.bios.2022.114410. Online ahead of print.ABSTRACTAcute stroke is the third leading cause of mortality and disability worldwide. Administration of appropriate therapy for acute stroke is critically dependent on timely classification into either ischemic or hemorrhagic subtypes, which have divergent treatment pathways. The current classification method is based on neuroimaging, which generally requires the transport of the patient to a hospital-based facility unless a mobile stroke unit is available. Plasma glial fibrillary acidic protein (GFAP) level has been identi...
Source: Biosensors and Bioelectronics - May 26, 2022 Category: Biotechnology Authors: Abkar Sayad Shah Mukim Uddin Scarlett Yao Harold Wilson Jianxiong Chan Henry Zhao Geoffrey Donnan Stephen Davis Efstratios Skafidas Bernard Yan Patrick Kwan Source Type: research

Scoring System to Predict Hospital Outcome After Subarachnoid Hemorrhage –Incorporating Systemic Response: The CRIG Score
Aneurysmal subarachnoid hemorrhage (aSAH) causes acute brain injury by deranging brain's microenvironment and has several systemic effects.1 Deleterious effects of acute brain injury after aSAH are manifested locally as early brain injury (EBI) and delayed cerebral ischemia (DCI).1 Pathological events like EBI and DCI both contribute to morbidity and mortality associated with aSAH. These local physiological derangements are difficult to study in vivo in humans and hence, investigators often rely on serological biomarkers to predict EBI and DCI after aSAH.
Source: Journal of Stroke and Cerebrovascular Diseases - May 24, 2022 Category: Neurology Authors: Mausaminben Y. Hathidara, Yesica Campos, Swathy Chandrashekhar, Chao Xu, DaiWai M. Olson, Aardhra Venkatachalam, Bappaditya Ray Source Type: research

Multicentre collection of uniform data on patients hospitalised for transient ischaemic attack or stroke in the Philippines: the Philippine Neurological Association One Database-Stroke (PNA1DB-Stroke) protocol
Introduction For scientific advances to translate into improved patient outcomes, systems of care must be in place to facilitate delivery of care. There is scarce information on quality of care and clinical outcome in our stroke patients. We aim to collect uniform data from patients with first or recurrent transient ischaemic attack (TIA) or ischaemic or haemorrhagic stroke to determine in-patient caseload, patient profile, types of diagnostic and therapeutic procedures, outcomes and overall quality of care among patients hospitalised for acute stroke in the Philippines. Methods and analysis This multicentre observational...
Source: BMJ Open - May 24, 2022 Category: General Medicine Authors: Philippine Neurological Association One Database - Stroke, Disease Study Management Group, Gan, Alvarez, Canete, Co, Collantes, Escabillas, Hiyadan, Juangco, Lokin, Macrohon-Valdez, Punsalan, Sarapuddin, Picar, Pascual V Tags: Open access, Neurology Source Type: research

Clostridium difficile Infection Does Not Impact Outcomes in Stroke Patients
This study investigates incidence, patient characteristics, clinical features, and outcomes of CDI following stroke, including ischemic stroke (IS), intracerebral hemorrhage (ICH), and aneurysmal subarachnoid hemorrhage (SAH). Methods: The hospital database was queried for all patients with IS, ICH, or SAH from 2010 through 2014. Patients who underwent testing for C. difficile testing (CDT) through polymerase chain reaction were assessed. Demographics, risk factors, clinical features, and outcomes were recorded. Fever was defined as temperature>101°F. Results: CDT was obtained in 555/4004 patients and was po...
Source: The Neurologist - May 1, 2022 Category: Neurology Tags: Original Articles Source Type: research

Outcomes of a Stroke Response Team on the Emergent Management of Intracerebral Hemorrhage
Discussion Implementation of a stroke response team increased the knowledge of the care team, improved the timeliness of blood pressure control, and decreased the time for emergency department arrival to a critical care bed, and to anticoagulation reversal agent administration.
Source: Dimensions of Critical Care Nursing - April 6, 2022 Category: Nursing Tags: Leadership DIMENSION Source Type: research

Data from New VOYAGER PAD Analyses at ACC.22 Reinforce Benefit of XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Peripheral Artery Disease (PAD) and Various Co-Morbid Conditions
RARITAN, N.J., April 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from new analyses from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefit of the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) in reducing severe vascular events in patients with PAD after lower-extremity revascularization (LER), a procedure that restores blood flow to the legs. Data from the two analyses demonstrate the role that the XARELTO® vascular dose plays in PAD patients with and without chronic kidney disease (CKD) and in PAD patients with and ...
Source: Johnson and Johnson - April 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news